ARTICLE SUMMARY:
Results from the Apple Heart Study show that the risk of false positive results was not as high as some had feared, but overall the study raised more questions than it answered.
One of the biggest fears when it comes to monitoring the population at large for chronic, but not immediately life-threatening, disorders such as atrial fibrillation (AF) is the possibility of false positive readings that can lead to costly and unnecessary follow-up testing.
